FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00448019 · COMPLETED
Trial details
- NCT number
- NCT00448019
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2014-10-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.